Delivery Order SPE2DB20D1100-SPE2DB24FB0Y5

Award Date 4/3/24
Potential Completion Date 4/4/24
Potential Value $12K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the procurement of BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has a potential value of $1,904.64 and a period of performance through February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation. This delivery order falls under an indefinite delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,055.70 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a pharmaceutical product known as the BREYNA 160-4.5 MCG INHALER 10.3GM. This delivery order contract has a completion date of March 7, 2024 and was awarded on March 6, 2024. AmerisourceBergen Drug Corp is the prime contractor for this contract, which is not designated as a set-aside contract....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This $2,052 contract is for the supply of the pharmaceutical product "BREYNA 80-4.5 MCG INHALER 10.3GM". The contract has a period of performance through March 28, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a BREYNA 80-4.5 MCG INHALER 10.3GM product. The award has a potential value of $3,475.55 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is issued under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 with a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,347.09 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of a pharmaceutical product, "BREYNA 160-4.5 MCG INHALER 10.3GM", to support military treatment programs and facilities. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The $56,325.38 firm fixed-price contract is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product. The contract has an ultimate completion date of September 30, 2024 and was awarded on September 27, 2024. There was no set-aside designation for this contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide BREYNA 80-4.5 MCG INHALER 10.3GM, a pharmaceutical product, in support of military treatment programs and facilities. The $2,562.19 delivery order has a completion date of March 7, 2024 and does not use any set-aside designations. Amerisourcebergen Drug Corp serves as the prime contractor under this order, which is part of...
This is a $3,030.94 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product, with a period of performance through April 16, 2024. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc. and is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract has a ceiling value of $2,535.26 and is for the delivery of the pharmaceutical product "BREYNA 160-4.5 MCG INHALER 10.3GM." The contract does not have a set-aside designation and is scheduled to be completed by April 1, 2024....
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product called BREYNA 80-4.5 MCG INHALER 10.3GM. The order, valued at $3,534.24, has a completion date of January 8, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received multiple federal contracts from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and related...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB0Y5
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of a pharmaceutical product, BREYNA 160-4.5 MCG INHALER 10.3GM. The contract, valued at $12,438.96, has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.

Generated 7/3/24, 9:39 AM